Dapagliflozin aids glycemic control in type 2 diabetes
(HealthDay) -- For patients with inadequately controlled type 2 diabetes, treatment with dapagliflozin is associated with improved glycemic control, stabilized insulin dosing, and weight reductions, according to research published in the March 20 issue of the Annals of Internal Medicine.
To evaluate the efficacy and safety of dapagliflozin, John P.H. Wilding, D.M., of University Hospital Aintree in Liverpool, U.K., and associates randomly assigned 800 patients with inadequately controlled type 2 diabetes, receiving at least 30 units of insulin daily, with or without up to two oral antidiabetic drugs, to receive a daily dose of dapagliflozin (2.5, 5, or 10 mg) or placebo for 48 weeks.
After 24 weeks, the researchers found that patients taking dapagliflozin had a 0.79 to 0.96 percent decrease in mean hemoglobin A1c, compared with a 0.39 percent decrease with placebo. The daily insulin dose decreased by 0.63 units with dapagliflozin compared with an increase of 5.65 units in the placebo group. Dapagliflozin was associated with a decrease of 0.92 to 1.61 kg in body weight, compared with an increase of 0.43 kg in the placebo group. At 48 weeks, these effects were maintained. Patients in the pooled dapagliflozin groups had a higher rate of hypoglycemic episodes compared with the placebo group (56.6 versus 51.8 percent).
"Dapagliflozin improves glycemic control, stabilizes insulin dosing, and reduces weight without increasing major hypoglycemic episodes in patients with inadequately controlled type 2 diabetes mellitus," the authors write.
The study was funded by AstraZeneca and Bristol-Myers Squibb, co-developers of dapagliflozin. Several of the authors are employees of AstraZeneca.
More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Journal reference:
Annals of Internal Medicine
Copyright © 2012 HealthDay. All rights reserved.
-
New type 2 diabetes drug helps lower blood sugar: study
Mar 20, 2012 |
not rated yet |
0
-
FDA questions safety of experimental diabetes drug
Jul 15, 2011 |
not rated yet |
0
-
Bristol-Myers gets EU approval for diabetes drug
Oct 05, 2009 |
not rated yet |
0
-
New drug improves glucose control without increasing risk of hypoglycemia in type 2 diabetes patients
Feb 26, 2012 |
not rated yet |
0
-
Sensor and insulin pump results in better blood-sugar control in all age groups with diabetes
Jun 29, 2010 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
I need help understanding the Fourier components of a square wave
1 hour ago
-
flow of current through zero potential difference
2 hours ago
-
Absorption of light by spherical nanoparticle
4 hours ago
-
Solvability of a circuit
9 hours ago
-
Question about perception of colors around light sources
12 hours ago
-
Does a charged particle rotate when traveling through a static Bf?
14 hours ago
- More from Physics Forums - Classical Physics
More news stories
Exercise prevents fructose-induced hypertriglyceridemia
(HealthDay)—Moderate aerobic exercise prevents fructose-induced hypertriglyceridemia in healthy males, according to a study published online May 14 in Diabetes.
Diabetes
May 17, 2013 |
5 / 5 (1) |
0
|
DNA variant affects diabetes risk and treatment response
A DNA variant near a digestive enzyme does not only affect risk of developing diabetes but also affects the response to treatment, an international consortium of researchers including the University of Dundee has found.
Diabetes
May 17, 2013 |
not rated yet |
0
|
The artificial pancreas that keeps tabs on sugar
(Medical Xpress)—Development of a sophisticated artificial pancreas holds potential to transform the lives of patients with Type 1 diabetes.
Diabetes
May 16, 2013 |
5 / 5 (1) |
0
|
Study findings significant for treating infections in Type 1 diabetes
A small University at Buffalo study has found for the first time that in Type 1 diabetics, insulin injections exert a strong anti-inflammatory effect at the cellular and molecular level, while even small amounts of glucose ...
Diabetes
May 16, 2013 |
not rated yet |
0
Hospital hypoglycemia rates up in black men with diabetes
(HealthDay)—Home diabetes regimens partially explain the increased risk of having a hypoglycemia event during hospitalization among older African-American men with diabetes, according to a study published ...
Diabetes
May 14, 2013 |
not rated yet |
0
US adviser on board of firm that sold anthrax drug
(AP)—Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while ...
Consumer group flags high SPF ratings on sunscreen
(AP)—Sunbathers this summer will find new sunscreen labels that are designed to make the products more effective and easier to use.
Treatment of sleep apnea improves glucose levels in prediabetes
Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in ...
Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak
Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics.
Blame your parents for bunion woes
A novel study reports that white men and women of European descent inherit common foot disorders, such as bunions (hallux valgus) and lesser toe deformities, including hammer or claw toe. Findings from the Framingham Foot ...
Genetic diversity within tumors predicts outcome in head and neck cancer
A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer. In the May 20 issue ...